GERCOR | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

453 results for “GERCOR”

Trials

View all 315 →

ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases

232 participants · First posted Mar 28, 2023

Multi-Line Therapy Trial in Unresectable Metastatic Colorectal Cancer

464 participants · First posted Jul 29, 2013

POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and Oesogastric

72 participants · First posted Feb 23, 2024

Drugs

View all 22 →

Tidutamab(Xencor, Inc.)

bevacizumab biosuperior (Xencor)

XmAb bispecific antibody(Xencor)

Organizations

View all 15 →

Xencor

United States

Hervor Therapeutics

China

MERCER UNIVERSITY

United States

News

View all 101 →

OSE2101 Cancer Vaccine Shows Promising Results in Phase 2 Pancreatic Cancer Trial

Geron's Imetelstat Shows Promise in MDS and Myelofibrosis Trials, NDA Submission on Track

Geron Corporation Advances in Myeloid Hematologic Malignancies Treatment

Page 1 of 46